RBM17 and thyroid gland papillary carcinoma: In papillary thyroid cancer, the 33-nt GlyGCC 5′tRNA half is upregulated and directly binds to RBM17 protein to induce alternative splicing of MAP4K4 mRNA, thereby showing tumor-promoting effects70.